Omega-3 fatty acid-derived resolvins and protectins in inflammation resolution and leukocyte functions: Targeting novel lipid mediator pathways in mitigation of acute kidney injury

Frontiers in Immunology

Volumn 4, Issue JAN, 2013, Pages

  Hong, Song ^a   Lu, Yan ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

14S; 21R diHDHA; Fibrosis; Inflammation resolution; Kidney injury; Leukocytes; Maresins; Protectins neuroprotectins; Resolvins

Indexed keywords

EID: 84874244260     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2013.00013     Document Type: Article

References (78)

1. Alikhan, M. A., Jones, C. V., Williams, T. M., Beckhouse, A. G., Fletcher, A. L., Kett, M. M., et al. (2011). Colony-stimulating factor-1 promotes kidney growth and repair via alteration of macrophage responses. Am.J. Pathol. 179, 1243-1256.
2. Ariel, A., Chiang, N., Arita, M., Petasis, N. A., and Serhan, C. N. (2003). Aspirin-triggered lipoxin A4 and B4 analogs block extracellular signal-regulated kinase-dependent TNF-alpha secretion from human T cells. J. Immunol. 170, 6266-6272.
3. Ariel, A., Li, P. L., Wang, W., Tang, W. X., Fredman, G., Hong, S., et al. (2005). The docosatriene protectin D1 is produced by TH2 skewing and promotes human T cell apop-tosis via lipid raft clustering. J. Biol. Chem. 280, 43079-43086.
4. Ariel, A., and Serhan, C. N. (2007). Resolvins and protectins in the termination program of acute inflammation. Trends Immunol. 28, 176-183.
5. Ariel, A., and Serhan, C. N. (2012). New lives given by cell death: macrophage differentiation following their encounter with apoptotic leukocytes during the resolution of inflammation. Front. Immunol. 3:4. doi: 10.3389/fimmu.2012.00004
6. Arita, M., Bianchini, F., Aliberti, J., Sher, A., Chiang, N., Hong, S., et al. (2005a). Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1. J. Exp. Med. 201, 713-722.
7. Arita, M., Yoshida, M., Hong, S., Tjonahen, E., Glickman, J. N., Petasis, N. A., et al. (2005b). Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2, 4, 6-trinitrobenzene sulfonic acid-induced colitis. Proc. Natl. Acad. Sci. U.S.A. 102, 7671-7676.
8. Arita, M., Oh, S. F., Chonan, T., Hong, S., Elangovan, S., Sun, Y. P., et al. (2006). Metabolic inactivation of resolvin E1 and stabilization of its anti-inflammatory actions. J. Biol. Chem. 281, 22847-22854.
9. Arita, M., Ohira, T., Sun, Y. P., Elangovan, S., Chiang, N., and Serhan, C. N. (2007). Resolvin E1 selectively interacts with leukotriene B4 receptor BLT1 and ChemR23 to regulate inflammation. J. Immunol. 178, 3912-3917.
10. Bannenberg, G. L., Chiang, N., Ariel, A., Arita, M., Tjonahen, E., Gotlinger, K. H., et al. (2005). Molecular circuits of resolution: formation and actions of resolvins and protectins. J. Immunol. 174, 4345-4355.
11. Bazan, N. G. (2005). Neuroprotectin D1 (NPD1): a DHA-derived mediator that protects brain and retina against cell injury-induced oxidative stress. Brain Pathol. 15, 159-166.
12. Bazan, N. G. (2012). The docosanoid neuroprotectin D1 induces homeostatic regulation of neu-roinflammation and cell survival. Prostaglandins Leukot. Essent. Fatty Acids 88, 127-129.
13. Bazan, N. G., Birkle, D. L., and Reddy, T. S. (1984). Docosahexaenoic acid (22:6, n-3) is metabolized to lipoxygenase reaction products in the retina. Biochem. Biophys. Res. Commun. 125, 741-747.
14. Bazan, N. G., Eady, T. N., Khoutorova, L., Atkins, K. D., Hong, S., Lu, Y., et al. (2012). Novel aspirin-triggered neuroprotectin D1 attenuates cerebral ischemic injury after experimental stroke. Exp. Neurol. 236, 122-130.
15. Bazan, N. G., Musto, A. E., and Knott, E. J. (2011). Endogenous signaling by omega-3 docosahexaenoic acid-derived mediators sustains homeostatic synaptic and circuitry integrity. Mol Neurobiol. 44, 216-222.
16. Bellomo, R., Kellum, J. A., and Ronco, C. (2012). Acute kidney injury. Lancet 380, 756-766.
17. 2+ increase in human bronchial epithelium. J. Biol. Chem. 278, 10879-10884.
18. Bonventre, J. V., and Yang, L. (2011). Cellular pathophysiology of ischemic acute kidney injury. J. Clin. Invest. 121, 4210-4221.
19. Borgeson, E., Docherty, N. G., Murphy, M., Rodgers, K., Ryan, A., O'Sullivan, T. P., et al. (2011). Lipoxin A(4) and benzo-lipoxin A(4) attenuate experimental renal fibrosis. FASEBJ. 25, 2967-2979.
20. Borgeson, E., and Godson, C. (2010). Molecular circuits of resolution in renal disease. Sci. World J. 10, 1370-1385.
21. Burne-Taney, M. J., Ascon, D. B., Daniels, F., Racusen, L., Baldwin, W., and Rabb, H. (2003). B cell deficiency confers protection from renal ischemia reperfusion injury. J. Immunol. 171, 3210-3215.
22. Duffield, J. S. (2010). Macrophages and immunologic inflammation of the kidney. Semin. Nephrol. 30, 234-254.
23. Duffield, J. S., and Bonventre, J. V. (2004). "Acute renal failure from Bench to Bedside, " in Chronic Kidney Disease, Dialysis and Transplant 42, 2nd Edn. eds B. J. G. Pereira, M. H. Sayegh, and P. Blake (Philadelphia, PA: Elsevier Saunders), 765-786.
24. Duffield, J. S., Hong, S., Vaidya, V. S., Lu, Y., Fredman, G., Serhan, C. N., et al. (2006). Resolvin D series and protectin D1 mitigate acute kidney injury. J. Immunol. 177, 5902-5911.
25. El Kebir, D., Gjorstrup, P., and Filep, J. G. (2012). Resolvin E1 promotes phagocytosis-induced neu-trophil apoptosis and accelerates resolution of pulmonary inflammation. Proc. Natl. Acad. Sci. U.S.A. 109, 14983-14988.
26. Faghiri, Z., and Bazan, N. G. (2010). PI3K/Akt and mTOR/p70S6K pathways mediate neuroprotectin D1-induced retinal pigment epithelial cell survival during oxidative stress-induced apoptosis. Exp. Eye Res. 90, 718-725.
27. Fiore, S., Maddox, J. F., Perez, H. D., and Serhan, C. N. (1994). Identification of a human cDNA encoding a functional high affinity lipoxin A4 receptor. J. Exp. Med. 150, 253-260.
28. Foell, D., Wittkowski, H., Vogl, T., and Roth, J. (2007). S100 proteins expressed in phagocytes: a novel group of damage-associated molecular pattern molecules. J. Leukoc. Biol. 81, 28-37.
29. Godson, C., Mitchell, S., Harvey, K., Petasis, N. A., Hogg, N., and Brady, H. R. (2000). Cutting edge: lipoxins rapidly stimulate nonphlo-gistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J. Immunol. 164, 1663-1667.
30. Hassan, I. R., and Gronert, K. (2009). Acute changes in dietary omega-3 and omega-6 polyunsaturated fatty acids have a pronounced impact on survival following ischemic renal injury and formation of renoprotec-tive docosahexaenoic acid-derived protectin D1. J. Immunol. 182, 3223-3232.
31. Hong, S., Gronert, K., Devchand, P. R., Moussignac, R. L., and Serhan, C. N. (2003). Novel docosatrienes and 17S-resolvins generated from docosahexaenoic acid in murine brain, human blood, and glial cells. Autacoids in anti-inflammation. J. Biol Chem. 278, 14677-14687.
32. Hong, S., Porter, T. F., Lu, Y., Oh, S. F., Pillai, P. S., and Serhan, C. N. (2008). Resolvin E1 metabolome in local inactivation during inflammation-resolution. J. Immunol. 180, 3512-3519.
33. Kato, S., Chmielewski, M., Honda, H., Pecoits-Filho, R., Matsuo, S., Yuzawa, Y., et al. (2008). Aspects of immune dysfunction in end-stage renal disease. Clin. J. Am. Soc. Nephrol. 3, 1526-1533.
34. Kelley, D. S., Taylor, P. C., Nelson, G. J., Schmidt, P. C., Ferretti, A., Erickson, K. L., et al. (1999). Docosahexaenoic acid ingestion inhibits natural killer cell activity and production of inflammatory mediators in young healthy men. Lipids 34, 317-324.
35. Kielar, M. L., Jeyarajah, D. R., Zhou, X. J., and Lu, C. Y. (2003). Docosahexaenoic acid ameliorates murine ischemic acute renal failure and prevents increases in mRNA abundance for both TNF-alpha and inducible nitric oxide synthase. J. Am. Soc. Nephrol. 14, 389-396.
36. Kieran, N. E., Maderna, P., and Godson, C. (2004). Lipoxins: potential anti-inflammatory, proresolution, and antifibrotic mediators in renal disease. Kidney Int. 65, 1145-1154.
37. Kieran, N. E., and Rabb, H. (2004). Immune responses in kidney preservation and reperfusion injury. J. Investig. Med. 52, 310-314.
38. Kluth, D. C. (2007). Pro-resolution properties of macrophages in renal injury. Kidney Int. 72, 234-236.
39. Ko, G. J., Boo, C. S., Jo, S. K., Cho, W. Y., and Kim, H. K. (2008). Macrophages contribute to the development of renal fibrosis following ischaemia/reperfusion-induced acute kidney injury. Nephrol. Dial. Transplant. 23, 842-852.
40. Ko, G. J., Zakaria, A., Womer, K. L., and Rabb, H. (2010). Immunologic research in kidney ischemia/reperfusion injury at Johns Hopkins University. Immunol. Res. 47, 78-85.
41. Kucharzik, T., Gewirtz, A. T., Merlin, D., Madara, J. L., and Williams, I. R. (2003). Lateral membrane LXA4 receptors mediate LXA4's anti-inflammatory actions on intestinal epithelium. Am. J. Physiol Cell Physiol. 284, C888-C896.
42. Lee, S., Huen, S., Nishio, H., Nishio, S., Lee, H. K., Choi, B. S., et al. (2011). Distinct macrophage phe-notypes contribute to kidney injury and repair. J. Am. Soc. Nephrol. 22, 317-326.
43. Leonard, M. O., Hannan, K., Burne, M. J., Lappin, D. W., Doran, P., Coleman, P., et al. (2002). 15-Epi-16-(para-fluorophenoxy)-lipoxin A(4)-methyl ester, a synthetic analogue of 15-epi-lipoxin A(4), is protective in experimental ischemic acute renal failure. J. Am. Soc. Nephrol. 13, 1657-1662.
44. Levy, B. D., Zhang, Q. Y., Bonnans, C., Primo, V., Reilly, J. J., Perkins, D. L., et al. (2011). The endogenous pro-resolving mediators lipoxin A4 and resolvin E1 preserve organ function in allograft rejection. Prostaglandins Leukot. Essent. Fatty Acids 84, 43-50.
45. Lu, Y., Tian, H., and Hong, S. (2010). Novel 14, 21-dihydroxy-docosahexaenoic acids: structures, formation pathways, and enhancement of wound healing. J. Lipid Res. 51, 923-932.
46. Lukiw, W. J., Cui, J. G., Marcheselli, V. L., Bodker, M., Botkjaer, A., Gotlinger, K., et al. (2005). A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J. Clin. Invest. 115, 2774-2783.
47. Maddox, J. F., Hachicha, M., Takano, T., Petasis, N. A., Fokin, V. V., and Serhan, C. N. (1997). Lipoxin A4 stable analogs are potent mimet-ics that stimulate human monocytes and THP-1 cells via a G-protein-linked lipoxin A4 receptor. J. Biol. Chem. 272, 6972-6978.
48. Maderna, P., and Godson, C. (2009). Lipoxins: resolutionary road. Br. J. Pharmacol. 158, 947-959.
49. Marcheselli, V. L., Hong, S., Lukiw, W. J., Tian, X. H., Gronert, K., Musto, A., et al. (2003). Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J. Biol. Chem. 278, 43807-43817.
50. Marcheselli, V. L., Mukherjee, P. K., Arita, M., Hong, S., Antony, R., Sheets, K., et al. (2010). Neuroprotectin D1/protectin D1 stereoselective and specific binding with human retinal pigment epithelial cells and neutrophils. Prostaglandins Leukot. Essent. Fatty Acids 82, 27-34.
51. McMahon, B., Stenson, C., Mcphillips, E, Fanning, A., Brady, H. R., and Godson, C. (2000). Lipoxin A4 antagonizes the mitogenic effects of leukotriene D4 in human renal mesangial cells. Differential activation of MAP kinases through distinct receptors. J. Biol. Chem. 275, 27566-27575.
52. Morgera, S., Kraft, A. K., Siebert, G., Luft, E C., and Neumayer, H. H. (2002). Long-term outcomes in acute renal failure patients treated with continuous renal replacement therapies. Am. J. Kidney Dis. 40, 275-279.
53. Mukherjee, P. K., Marcheselli, V. L., Serhan, C. N., and Bazan, N. G. (2004). Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc. Natl. Acad. Sci. U.S.A. 101, 8491-8496.
54. Mulay, S. R., Thomasova, D., Ryu, M., and Anders, H. J. (2012). MDM2 (murine double minute-2) links inflammation and tubular cell healing during acute kidney injury in mice. Kidney Int. 81, 1199-1211.
55. Negi, S., and Shigematsu, T. (2012). Current therapeutic strategies for acute kidney injury. Clin. Exp. Nephrol. 16, 672-678.
56. Neumayer, H. H., Heinrich, M., Schmissas, M., Haller, H., Wagner, K., and Luft, E C. (1992). Amelioration of ischemic acute renal failure by dietary fish oil administration in conscious dogs. J. Am. Soc. Nephrol. 3, 1312-1320.
57. Nishida, M., Okumura, Y., Fujimoto, S., Shiraishi, I., Itoi, T., and Hamaoka, K. (2005). Adoptive transfer of macrophages ameliorates renal fibrosis in mice. Biochem. Biophys. Res. Commun. 332, 11-16.
58. Ohira, T., Arita, M., Omori, K., Recchiuti, A., Van Dyke, T. E., and Serhan, C. N. (2010). Resolvin E1 receptor activation signals phosphorylation and phagocytosis. J.Biol. Chem. 285, 3451-3461.
59. Schif-Zuck, S., Gross, N., Assi, S., Rostoker, R., Serhan, C. N., and Ariel, A. (2011). Saturated-efferocytosis gener-ates pro-resolving CD 11b low macrophages: modulation by resolvins and glucocorticoids. Eur. J. Immunol. 41, 366-379.
60. Schwab, J. M., Chiang, N., Arita, M., and Serhan, C. N. (2007). Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 447, 869-874.
61. Serhan, C. N. (2011). The resolution of inflammation: the devil in the flask and in the details. FASEBI 25, 1441-1448.
62. Serhan, C. N., Clish, C. B., Brannon, J., Colgan, S. P., Chiang, N., and Gronert, K. (2000). Novel functional sets of lipid-derived mediators with antiinflammatory actions generated from omega-3 fatty acids via cyclooxygenase 2-nonsteroidal antiinflammatory drugs and transcellular processing. J. Exp. Med. 192, 1197-1204.
63. Serhan, C. N., Gotlinger, K., Hong, S., Lu, Y., Siegelman, J., Baer, T., et al. (2006). Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes. J. Immunol. 176, 1848-1859.
64. Serhan, C. N., Hong, S., Gronert, K., Colgan, S. P., Devchand, P. R., Mirick, G., et al. (2002). Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals.J. Exp. Med. 196, 1025-1037.
65. Serhan, C. N., and Petasis, N. A. (2011). Resolvins and protectins in inflammation resolution. Chem. Rev. 111, 5922-5943.
66. Serhan, C. N., Yang, R., Martinod, K., Kasuga, K., Pillai, P. S., Porter, T. E, et al. (2009). Maresins: novel macrophage mediators with potent antiinflammatory and proresolving actions.J. Exp. Med. 206, 15-23.
67. Simopoulos, A. P. (2002). Omega-3 fatty acids in inflammation and autoimmune diseases. J. Am. Coll. Nutr. 21, 495-505.
68. Spite, M., Norling, L. V., Summers, L., Yang, R., Cooper, D., Petasis, N. A., et al. (2009). Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Nature 461, 1287-1291.
69. Sun, Y. P., Oh, S. F., Uddin, J., Yang, R., Gotlinger, K., Campbell, E., et al. (2007). Resolvin D1 and its aspirin-triggered 17R epimer. Stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. J. Biol. Chem. 282, 9323-9334.
70. Tian, H., Lu, Y., Shah, S. P., and Hong, S. (2010). Novel 14S, 21-dihydroxy-docosahexaenoic acid rescues wound healing and associated angiogenesis impaired by acute ethanol intoxication/exposure. J. Cell. Biochem. 111, 266-273.
71. Tian, H., Lu, Y., Shah, S. P., and Hong, S. (2011a). 14S, 21R-dihydroxydocosahexaenoic acid remedies impaired healing and mesenchymal stem cell functions in diabetic wounds. J. Biol. Chem. 286, 4443-4453.
72. Tian, H., Lu, Y., Shah, S. P., and Hong, S. (2011b). Autacoid 14S, 21R-dihydroxy-docosahexaenoic acid counteracts diabetic impairment of macrophage prohealing functions. Am. I Pathol. 179, 1780-1791.
73. Tian, H., Lu, Y., Shah, S. P., Wang, Q., and Hong, S. (2012). 14S, 2 1R-dihydroxy-docosahexaenoic acid treatment enhances mesenchymal stem cell amelioration of renal ischemia/reperfusion injury. Stem Cells Dev. 21, 1187-1199.
74. Tian, H., Lu, Y., Sherwood, A. M., Hongqian, D., and Hong, S. (2009). Resolvins E1 and D1 in choroid-retinal endothelial cells and leukocytes: biosynthesis and mechanisms of anti-inflammatory actions. Invest. Ophthalmol. Vis. Sci. 50, 3613-3620.
75. Togel, F., Hu, Z., Weiss, K., Isaac, J., Lange, C., and Westenfelder, C. (2005). Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms. Am. J. Physiol. Renal Physiol. 289, F31-F42.
76. Vernon, M. A., Mylonas, K. J., and Hughes, J. (2010). Macrophages and renal fibrosis. Semin. Nephrol. 30, 302-317.
77. Wu, S. H., Liao, P. Y., Dong, L., and Jiang, X. Y (2006). [Protective effects of 15-methyl-lipoxin A4 on mesangioproliferative nephritis in rats]. Zhongguo Dang Dai Er Ke Za Zhi 8, 225-230.
78. Young, B. A., Burdmann, E. A., Johnson, R. J., Alpers, C. E., Giachelli, C. M., Eng, E., et al. (1995). Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity. Kidney Int. 48, 439-448.